Suhardi, Kevin Fernando, et al. “Empagliflozin for Liver and Lipid Profile in Metabolic Dysfunction-Associated Fatty Liver Disease: A Meta-Analysis”. Medical Journal of Indonesia, vol. 34, no. 4, Nov. 2025, pp. 268–77, doi:10.13181/mji.oa.257855.